| |
| |
|
| Insider
Information: |
Subramanian Sanjay |
| Relationship: |
SVP, CFO |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
191,523 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,102 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
191,523 |
|
|
| Total
Value |
$26,102 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ocugen Ord Shs |
OCGN |
Chief Financial Officer |
2022-01-03 |
161,125 |
2019-10-02 |
0 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
SVP, CFO |
2023-09-29 |
30,398 |
2022-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INZY |
Inozyme Pharma, Inc. |
SVP, CFO |
• – – |
2023-09-29 |
4 |
A |
$3.57 |
$8,279 |
D/D |
2,319 |
30,398 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
SVP, CFO |
• – – |
2022-04-19 |
4 |
B |
$3.69 |
$99,999 |
D/D |
27,100 |
27,100 |
2.74 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
125,534 |
161,125 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-10-26 |
4 |
AS |
$11.07 |
$110,700 |
D/D |
(10,000) |
35,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-10-15 |
4 |
AS |
$9.96 |
$79,580 |
D/D |
(7,990) |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-10-15 |
4 |
OE |
$2.19 |
$17,498 |
D/D |
7,990 |
53,581 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-08-16 |
4 |
AS |
$7.22 |
$216,600 |
D/D |
(30,000) |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-08-16 |
4 |
OE |
$0.34 |
$10,200 |
D/D |
30,000 |
75,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-07-15 |
4 |
AS |
$6.70 |
$208,276 |
D/D |
(31,086) |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-07-15 |
4 |
OE |
$0.34 |
$10,569 |
D/D |
31,086 |
76,677 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-06-15 |
4 |
AS |
$7.00 |
$217,000 |
D/D |
(31,000) |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-06-15 |
4 |
OE |
$0.34 |
$10,540 |
D/D |
31,000 |
76,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-05-14 |
4 |
AS |
$8.18 |
$253,673 |
D/D |
(31,000) |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-05-14 |
4 |
OE |
$0.34 |
$10,540 |
D/D |
31,000 |
76,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
AS |
$10.98 |
$87,730 |
D/D |
(7,990) |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
OE |
$2.19 |
$17,498 |
D/D |
7,990 |
53,581 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2021-01-29 |
4 |
OE |
$0.51 |
$18,151 |
D/D |
35,591 |
45,591 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2019-11-22 |
4 |
B |
$0.28 |
$1,400 |
D/D |
5,000 |
10,000 |
2.66 |
- |
|
| OCGN |
Ocugen Ord Shs |
Chief Financial Officer |
• – – |
2019-10-02 |
4 |
B |
$1.88 |
$9,400 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
